PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Cancer 1,053,491 Disease Target CCL14 34 6 0.00 -0.91 0.18 0.55
Cancer 1,053,491 Disease Target EG-VEGF 63 11 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target Endoglin 1,333 232 0.01 -0.91 0.17 0.57
Cancer 1,053,491 Disease Disease Mucus In Stool 23 4 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target BMX 185 32 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target CXCL3 145 25 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target ENO2 87 15 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Apo D 105 18 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Glutathione S-Transferase A1 111 19 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target ETS1 539 92 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Disease Warts 5,574 942 0.01 -0.91 0.17 0.58
Cancer 1,053,491 Disease Target Steroid 5-Alpha-Reductase 293 49 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Drug Arranon (Nelarabine)- FDA 12 2 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target E9 protein 6 1 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Drug Acular (Ketorolac Tromethamine)- FDA 6 1 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target ERK1 18,374 2,955 0.02 -0.91 0.16 0.59
Cancer 1,053,491 Disease Disease Brain Tumors 16,749 2,693 0.02 -0.91 0.16 0.59
Cancer 1,053,491 Disease Target Signal Transducer And Activator Of Transcription 5b 82 13 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Target CXCL7 76 12 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Drug Aralen (Chloroquine)- FDA 19 3 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Disease Gynecomastia 2,594 407 0.01 -0.92 0.16 0.57
Cancer 1,053,491 Disease Disease Skin Rash 3,684 578 0.01 -0.92 0.16 0.58
Cancer 1,053,491 Disease Target CCL18 256 40 0.00 -0.92 0.16 0.56
Cancer 1,053,491 Disease Target Methylenetetrahydrofolate Reductase 3,573 555 0.01 -0.92 0.16 0.58
Cancer 1,053,491 Disease Target Hyaluronidase-1 52 8 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target AURKC 26 4 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target Chorionic Gonadotropin beta 936 141 0.00 -0.92 0.15 0.56
Cancer 1,053,491 Disease Target Macrophage Metalloelastase 100 15 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Drug Dracorhodin 20 3 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Drug Antabuse (Disulfiram)- FDA 27 4 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target EPHB1 137 20 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target CLK1 62 9 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Disease Postgastrectomy 829 120 0.00 -0.92 0.14 0.56
Cancer 1,053,491 Disease Target FABP1 90 13 0.00 -0.92 0.14 0.55
Cancer 1,053,491 Disease Target AMY2B 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target CAMK2B 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target Alpha Platelet-Derived Growth Factor Receptor 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Drug Abciximab (ReoPro)- FDA 7 1 0.00 -0.93 0.14 0.54
Cancer 1,053,491 Disease Drug Kabiramide C 7 1 0.00 -0.93 0.14 0.54
Cancer 1,053,491 Disease Target CCL21 808 113 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Disease Leukemias 14,152 1,978 0.02 -0.93 0.14 0.59
Cancer 1,053,491 Disease Target Retinoic Acid Receptor Alpha 1,068 149 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Disease Andropause 317 44 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Target CA 50 1,293 178 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Target DC-CK1 22 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Drug Drupanin 22 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target ANGPT2 105 14 0.00 -0.93 0.13 0.55
Cancer 1,053,491 Disease Drug Kaempferide 60 8 0.00 -0.93 0.13 0.55
Cancer 1,053,491 Disease Target Peroxisome Proliferator-Activated Receptor Delta 355 47 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Drug Alendronate Sodium (Fosamax)- FDA 38 5 0.00 -0.93 0.13 0.55